Leidos Concludes Initial Performance Trials of Unmanned Sea Hunter off San Diego Coast

Leidos, a national security, health, and infrastructure solutions company, announced today that on June 22, it completed initial performance trials of the technology demonstration vessel it is developing for the Defense Advanced Research Projects Agency (DARPA)'s Anti-Submarine Warfare Continuous Trail Unmanned Vessel (ACTUV) program. The at-sea tests took place off the coast of San Diego, California.

The 132-foot trimaran, christened Sea Hunter at a ceremony in April, met or surpassed all performance objectives for speed, maneuverability, stability, seakeeping, acceleration/deceleration, and fuel consumption, as well as establishing confidence in mechanical systems reliability in an open-ocean environment. Sea Hunter is designed to operate for extended periods at sea with no person on board and only sparse supervisory control throughout deployment. While initial vessel tests require a pilot on board the ship, later tests are planned to have no personnel on board.

The completion of Sea Hunter's performance trials is the first milestone in the two-year test program co-sponsored by DARPA and the Office of Naval Research. Testing in upcoming months is scheduled to include testing of sensors, the vessel's autonomy suite, compliance with maritime collision regulations, and proof-of-concept demonstrations for a variety of U.S. Navy missions.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.